ALLMedicine™ Hyperviscosity Syndrome Center
Research & Reviews 137 results
https://doi.org/10.1016/j.clml.2020.08.019
Clinical Lymphoma, Myeloma & Leukemia; Mina R, Bonello F et. al.
Oct 30th, 2020 - Daratumumab-Based Therapy for IgM Multiple Myeloma With Hyperviscosity Syndrome: A Case Report.|2020|Mina R,Bonello F,Gay F,Zamagni E,Boccadoro M,|
https://doi.org/10.1016/j.transci.2020.102898
Transfusion and Apheresis Science : Official Journal of T... Singh C, Lad D et. al.
Aug 11th, 2020 - Symptomatic hyperviscosity is an oncologic emergency which is suspected when patients with certain hematogical malignancies present with neurological symptoms. Hyperviscosity syndrome is a rare clinical manifestation in multiple myeloma. We descri...
https://doi.org/10.1016/j.clml.2020.06.016
Clinical Lymphoma, Myeloma & Leukemia; Boiten HJ, Buijze M et. al.
Jul 21st, 2020 - Ixazomib Treatment of IgA Multiple Myeloma With Hyperviscosity Syndrome.|2020|Boiten HJ,Buijze M,Zweegman S,Levin MD,|
https://doi.org/10.1007/s12185-020-02917-7
International Journal of Hematology; Yoshimura T, Hayashi Y et. al.
Jun 23rd, 2020 - Hyperviscosity syndrome (HVS) can cause multiple organ damage if not treated immediately. IgM multiple myeloma (IgM MM) is a very rare form of myeloma with clinical features such as elevated serum IgM, and anemia, that resemble Waldenström macrogl...
https://doi.org/10.1016/j.jep.2020.113078
Journal of Ethnopharmacology; Gao D, Wu SN et. al.
Jun 13th, 2020 - Hyperviscosity syndrome (HVS) is a major risk factor for thrombotic diseases. Rhubarb, well-known as a traditional Chinese medicine, exhibits multiple pharmacological activities, especially for promoting blood circulation to remove blood stasis (P...
Clinicaltrials.gov 137 results
https://doi.org/10.1016/j.clml.2020.08.019
Clinical Lymphoma, Myeloma & Leukemia; Mina R, Bonello F et. al.
Oct 30th, 2020 - Daratumumab-Based Therapy for IgM Multiple Myeloma With Hyperviscosity Syndrome: A Case Report.|2020|Mina R,Bonello F,Gay F,Zamagni E,Boccadoro M,|
https://doi.org/10.1016/j.transci.2020.102898
Transfusion and Apheresis Science : Official Journal of T... Singh C, Lad D et. al.
Aug 11th, 2020 - Symptomatic hyperviscosity is an oncologic emergency which is suspected when patients with certain hematogical malignancies present with neurological symptoms. Hyperviscosity syndrome is a rare clinical manifestation in multiple myeloma. We descri...
https://doi.org/10.1016/j.clml.2020.06.016
Clinical Lymphoma, Myeloma & Leukemia; Boiten HJ, Buijze M et. al.
Jul 21st, 2020 - Ixazomib Treatment of IgA Multiple Myeloma With Hyperviscosity Syndrome.|2020|Boiten HJ,Buijze M,Zweegman S,Levin MD,|
https://doi.org/10.1007/s12185-020-02917-7
International Journal of Hematology; Yoshimura T, Hayashi Y et. al.
Jun 23rd, 2020 - Hyperviscosity syndrome (HVS) can cause multiple organ damage if not treated immediately. IgM multiple myeloma (IgM MM) is a very rare form of myeloma with clinical features such as elevated serum IgM, and anemia, that resemble Waldenström macrogl...
https://doi.org/10.1016/j.jep.2020.113078
Journal of Ethnopharmacology; Gao D, Wu SN et. al.
Jun 13th, 2020 - Hyperviscosity syndrome (HVS) is a major risk factor for thrombotic diseases. Rhubarb, well-known as a traditional Chinese medicine, exhibits multiple pharmacological activities, especially for promoting blood circulation to remove blood stasis (P...
News 1 results
https://www.mdedge.com/hematology-oncology/article/162787/multiple-myeloma/age-and-race-affect-access-myeloma-treatment/page/0/1
Apr 6th, 2018 - Similarly increased odds of no treatment were reported for patients with comorbidities and poor performance status indicators. “In a subset of older and frail patients, the risks of treatments approved for [multiple myeloma] might outweigh the ben.
